Physician profile
Andrea B Moore
NPI 1437146891
$1,010.84
in general payments reported to CMS, 2019-2025
18 companies · $181 in 2025
The $181 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $204 · 2020: $73.16 · 2022: $143 · 2023: $168 · 2024: $242 · 2025: $181.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $491 · Education: $99.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $490.80 |
| Education | $99.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $194.46 | 2019-2025 | Veozah |
| Organon LLC | $136.57 | 2023-2024 | Nexplanon |
| Abbvie INC. | $79.84 | 2020-2022 | |
| Pfizer INC. | $77.41 | 2019-2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $71.68 | 2019-2025 | |
| Sumitomo Pharma America, INC. | $70.83 | 2023-2025 | Myfembree, Gemtesa |
| Biogen, INC. | $70.76 | 2024-2025 | Zurzuvae |
| Allergan, INC. | $58.79 | 2019 | |
| Coopersurgical, INC. | $57.59 | 2019-2022 | |
| Hologic Sales and Service, LLC | $51.51 | 2022-2025 | Novasure, Myosure Tissue Removal Device |
| Daiichi Sankyo INC. | $26.59 | 2024 | Injectafer |
| Mayne Pharma Commercial LLC | $22.07 | 2025 | |
| Axonics, INC. | $18.62 | 2024 | Bulkamid, Axonics |
| Glaxosmithkline, LLC. | $18.25 | 2025 | Benlysta |
| Urovant Sciences INC | $15.99 | 2022 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Myovant Sciences INC. | $14.93 | 2022 | |
| Amgen INC. | $13.23 | 2023 | Prolia, Evenity |
| Merck Sharp & Dohme LLC | $11.72 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Andrea Moore listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.